Related references
Note: Only part of the references are listed.NATALIZUMAB-ASSOCIATED PML IDENTIFIED IN THE PRESYMPTOMATIC PHASE USING MRI SURVEILLANCE
Nicholas F. Blair et al.
NEUROLOGY (2012)
Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Augusto Miravalle et al.
ARCHIVES OF NEUROLOGY (2011)
Immune reconstitution inflammatory syndrome and the central nervous system
Tory Johnson et al.
CURRENT OPINION IN NEUROLOGY (2011)
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Joseph R. Berger et al.
ANNALS OF NEUROLOGY (2009)
Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis
Azza Ismail et al.
JOURNAL OF NEUROLOGY (2009)
Immune reconstitution inflammatory syndrome of the brain: Case illustrations of a challenging entity
Elisabeth J. Rushing et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Melanoma complicating treatment with natalizumab for multiple sclerosis
John T. Mullen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
